ULTRACONTOUR UNIQUE HIFU BODY CONTOURING

ULTRACONTOUR HAS SELECTED THE LATEST TECHNOLOGY IN THERAPEUTIC HIFU TRANSDUCERS
•Offer a unique patented dual therapy based on safe, clinically tested therapeutic ultrasounds to treat subdermal fat.

HIGH TECHNOLOGY FOCAL ULTRASOUNDS which have three majors effects in FAT CELLS :

First they do de-polymerisation or molecular dissociation of the tri-glyceride and increase their fluidity.

Second Lipolysis or ejection of fat acid outside of adipocyte is made via the stable cavitation phenomena and by the increase of the permeability of the adipocyte.

Third Defibrosis by the mechanical action of the connective tissue in the hypodermis;-UMD ULTRASOUNDS to treat fat is then liberate in the interstitial tissue, and it will be necessary to vacuate them as soon as possible via natural drainage before they get recapture by the adipocyte


DOCTOR Kostas Gritzalas, Dermatologist in Mediapsis clinic, member of the SIMOE society was guest in Philippins Manilla, in Seoul Korea and in Delhi where several successful meeting of presentation to Dermatologists and Plastic Surgeons, of this new non invasive system has been made this summer.
More than 100 Doctors have tried and consequently decided to put it into their clinic and cosmetic surgery hospitals.

Doctors believe that this new technique totally non invasive and painless with No down time is the future for their patients who can have a treatment even during their lunch break... and loose centimeters in abdomen and legs.
"Treat yourself to a new body contour"

Ultracontour is affordable for doctors and propose to them the most complete, compact advance system for HIFU in the world.

Totally safe with visual and software control of the patient treatment during the whole process that last only one hour.

Medixsysteme is a Medical Aesthetic company manufacturer based in FRANCE, and is accreditated ISO 9001 - 13485 medical.

Doctors and patients can find more on our system on www.ultracontour.info as well as ask their medical question to our Medical Director by email.
This artilce has been viewed: 0 times this month, and 0 times in total since published.